A detailed history of Gs Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Gs Investments, Inc. holds 11,383 shares of AMGN stock, worth $3 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
11,383
Previous 11,393 0.09%
Holding current value
$3 Million
Previous $3.56 Million 3.03%
% of portfolio
1.64%
Previous 1.68%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $3,093 - $3,373
-10 Reduced 0.09%
11,383 $3.67 Million
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $9,459 - $11,495
-36 Reduced 0.31%
11,393 $3.56 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $38,448 - $46,412
143 Added 1.27%
11,429 $3.25 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $8,949 - $10,096
35 Added 0.31%
11,286 $3.25 Million
Q3 2023

Nov 01, 2023

SELL
$218.65 - $271.46 $37,170 - $46,148
-170 Reduced 1.49%
11,251 $3.02 Million
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $3,214 - $3,800
-15 Reduced 0.13%
11,421 $2.54 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $5,725 - $7,275
25 Added 0.22%
11,436 $3 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $4,713 - $5,316
-21 Reduced 0.18%
11,411 $2.57 Million
Q2 2022

Aug 03, 2022

SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 0.26%
11,432 $2.79 Million
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $24,119 - $26,682
110 Added 0.97%
11,462 $2.89 Million
Q4 2021

Feb 09, 2022

SELL
$198.88 - $227.6 $17,899 - $20,484
-90 Reduced 0.79%
11,352 $2.55 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $2.43 Million - $2.85 Million
11,442 New
11,442 $2.43 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $1.4 Million - $1.63 Million
-6,290 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $1.36 Million - $1.62 Million
6,290 New
6,290 $1.45 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $2.75 Million - $3.05 Million
-11,700 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $12,462 - $15,292
-63 Reduced 0.54%
11,700 $2.76 Billion
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $23,508 - $31,179
-129 Reduced 1.08%
11,763 $2.38 Billion
Q4 2019

Feb 04, 2020

SELL
$189.21 - $243.2 $77,765 - $99,955
-411 Reduced 3.34%
11,892 $2.2 Billion
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $67,902 - $81,361
-390 Reduced 3.07%
12,303 $2.38 Billion
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $55,844 - $65,462
335 Added 2.71%
12,693 $2.34 Billion
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $1,808 - $2,038
10 Added 0.08%
12,358 $2.35 Billion
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $2,676 - $3,123
15 Added 0.12%
12,348 $2.4 Billion
Q3 2018

Nov 06, 2018

BUY
$185.29 - $208.89 $31,684 - $35,720
171 Added 1.41%
12,333 $2.56 Billion
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $87,176 - $97,917
-525 Reduced 4.14%
12,162 $2.24 Billion
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $42,357 - $49,500
250 Added 2.01%
12,687 $2.16 Billion
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $16,035 - $17,916
95 Added 0.77%
12,437 $2.16 Billion
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $6,357 - $7,258
38 Added 0.31%
12,342 $2.3 Billion
Q2 2017

Aug 29, 2017

BUY
N/A
12,304
12,304 $2.12 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gs Investments, Inc. Portfolio

Follow Gs Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gs Investments, Inc. with notifications on news.